Aspirin Therapy Under Review

An aspirin a day used to be the recommendation for stroke and heart attack patients for preventative measures.

However the risk of heavy internal bleeding is worse than the potential benefits, especially to healthy people.

The message seems to be that aspirin therapy causes more harm than it’s worth.

Currently, U.S. guidelines all recommend aspirin for primary prevention as long as the benefits outweigh the harms, an equation that depends on baseline risk. This advice is backed by an editorial accompanying the new report.

Daily Aspirin Therapy Tied to Loss of Vision

Although daily aspirin therapy is recommended to prevent heart attack and stroke it has been shown to contribute to macular degeneration in seniors.

The study, published in the journal Ophthalmology, included Norwegian, Estonian, British, French, Italian, Greek and Spanish seniors.

Of the 839 people who took aspirin each day, 36 had an advanced form of the disease called wet macular degeneration.

This equates to about four out of every 100 daily aspirin users.

In comparison, roughly two out of every 100 people who took aspirin less frequently had the same type of macular degeneration.

Related Posts